Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-11-30

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The principle aim of the project is to analyze brain electrical activity and genetic information that will help identify the nature and cause of the disease schizophrenia. This effort should lay the groundwork for future treatment in schizophrenic patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neurophysiological Studies in Schizophrenia and Psychiatric Disorders

NCT01384604

Schizophrenia Schizoaffective Disorder Bipolar Disorder

COMPLETED

The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia

NCT00247637

Schizophrenia

COMPLETED

Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia

NCT01036568

Schizophrenia Psychosis

COMPLETED

Familial Schizophrenia and Spectrum Personality Disorders

NCT00666146

Schizophrenia

COMPLETED

Genetic Study of Schizophrenia

NCT00001486

Schizoaffective Disorder Schizophrenia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are several studies and hypotheses to be tested. This project includes a cross-sectional study design measuring brain waves, clinical symptoms, cognitive and functional ability, and genetic information in schizophrenic patients and normal controls. Subjects are expected to do a brain wave recording (EEG/ERP), role-play test designed to measure functionality and cognitive ability, and clinical symptom assessments. Expected duration of subject participation will be approximately 8 hours (about 2 visits). Outcome measures includes biomarkers, clinical symptoms and function, and genetic information.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Schizophrenic patients, family members

Schizophrenia Spectrum Disorder Patients

No interventions assigned to this group

Controls

Normal controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and Female between ages 14-62 (clinical assessment and blood draw only above 62)
* Ability to give written assent (subjects who are below the age of 18)
* Ability to give written informed consent (age 18 or above)
* Sufficient understanding of the study and risks (ESC score 10 or above)
* Subjects above age 62 will not participate in brain electrical activity measurements although they may still participate in clinical assessments and blood draw.

Exclusion Criteria

* Inability to sign informed consent/assent
* Any major medical illness that may affect normal brain functioning. Examples of these conditions include, but not limited to, stroke, repeated seizure, history of significant head trauma, CNS infection or tumor, an other significant brain neurological conditions.
* Significant alcohol or drug use (substance dependence within 6 months or substance abuse within 1 month) other than nicotine or marijuana dependence.
* Woman who is pregnant (child bearing potential but not on contraceptive and missing menstrual period; or by self-report; or by positive pregnancy test).
* Can not refrain from using alcohol and/or marijuana 24 hours or more\& cigarette smoking half and hour or more prior to experiments.

Minimum Eligible Age

14 Years

Maximum Eligible Age

62 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes